Table Of Contents
1 Introduction 11
1.1 Objectives Of The Study 11
1.2 Market Definition 11
1.3 Overview Of North America Oligosaccharides In Infant Nutrition Market 12
1.4 Currency And Pricing 13
1.5 Limitation 13
1.6 Markets Covered 14
2 Market Segmentation 16
2.1 Markets Covered 16
2.2 Geographic Scope 17
2.3 Years Considered For The Study 18
2.4 Currency And Pricing 18
2.5 Research Methodology 19
2.6 Primary Interviews With Key Opinion Leaders 22
2.7 Dbmr Market Position Grid 23
2.8 Secondary Sources 25
2.9 Assumptions 25
3 Market Overview 26
3.1 Drivers 28
3.1.1 Growing Number Of Working Mothers 28
3.1.2 Rising Birth Rate 29
3.1.3 Inability Of Mothers To Lactate Sufficiently 30
3.1.4 Health Benefits Offered By Infant Formula Or Oligosacharide 30
3.2 Restraints 31
3.2.1 Threat Of Allergies Or Autoimmune Diseases 31
3.2.2 Stringent Regulations 31
3.2.3 Increasing Awareness For Natural Infant Feeding 32
3.3 Opportunity 32
3.3.1 Increasing Demand Of Organic Products 32
3.4 Challenge 33
3.4.1 High Cost Of Products 33
4 Executive Summary 34
5 Premium Insights 36
6 North America Oligosachride In Infant Nutrition Market, By Type 39
6.1 Overview 40
6.2 Galactooligosaccharides 42
6.3 Human Milk Oligosaccharides 43
6.3.1 Fucosyllactose 43
6.3.2 Lnt & Lnnt 43
6.3.3 Sialyllactose 43
6.4 Fructoligosaccharides 44
6.5 Others 45
7 North America Oligosachride In Infant Nutrition Market, By Source 46
7.1 Overview 47
7.2 Bacteria 49
7.3 Plants 50
7.4 Algae 51
7.5 Fungi 52
7.6 Others 53
8 North America Oligosachride In Infant Nutrition Market, By Form 54
8.1 Overview 55
8.2 Powder 56
8.3 Liquid 57
9 North America Oligosaccharides In Infant Nutrition Market, By Geography 58
9.1 North America 58
9.1.1 U.S. 66
9.1.2 Canada 68
9.1.3 Mexico 70
10 North America Oligosaccharides In Infant Nutrition Market, Company Landscape 72
10.1 Company Share Analysis; North America 72
11 Company Profile 73
11.1 Dupont Nutrition & Health (Subsidiary Of Dupont) 73
11.1.1 Company Overview 73
11.1.2 Geographic Presence 73
11.1.3 Company Share Analysis 74
11.1.4 Product Portfolio 74
11.1.5 Recent Developments 74
11.2 Frieslandcampina Domo (Subsidiary Of Koninklijke Frieslandcampina Nv) 75
11.2.1 Company Overview 75
11.2.2 Revenue Analysis 75
11.2.3 Company Share Analysis 76
11.2.4 Product Portfolio 76
11.2.5 Recent Developments 76
11.3 Abbott 77
11.3.1 Company Overview 77
11.3.2 Revenue Analysis 77
11.3.3 Company Share Analysis 78
11.3.4 Product Portfolio 78
11.3.5 Recent Developments 78
11.4 Ingredion 79
11.4.1 Company Overview 79
11.4.2 Revenue Analysis 79
11.4.3 Company Share Analysis 80
11.4.4 Product Portfolio 80
11.4.5 Recent Developments 80
11.5 Carbosynth 81
11.5.1 Company Overview 81
11.5.2 North America Presence 81
11.5.3 Product Portfolio 82
11.5.4 Recent Developments 82
11.6 Dairy Crest 83
11.6.1 Company Overview 83
11.6.2 Revenue Analysis 83
11.6.3 Product Portfolio 84
11.6.4 Recent Developments 84
11.7 Dextra Laboratories Limited 85
11.7.1 Company Overview 85
11.7.2 Geographic Presence 85
11.7.3 Product Portfolio 86
11.7.4 Recent Developments 86
11.8 Elicityl 87
11.8.1 Company Overview 87
11.8.2 Geographic Presence 87
11.8.3 Product Portfolio 88
11.8.4 Recent Developments 88
11.9 Inbiose Nv. 89
11.9.1 Company Overview 89
11.9.2 Product Portfolio 89
11.9.3 Recent Developments 89
11.10 Jennewein Biotechnologie Gmbh 90
11.10.1 Company Overview 90
11.10.2 Geographic Presence 90
11.10.3 Product Portfolio 91
11.10.4 Recent Developments 91
11.11 Tereos 92
11.11.1 Company Overview 92
11.11.2 Revenue Analysis 92
11.11.3 Product Portfolio 93
11.11.4 Research Devlopment 93
11.12 Zuchem 94
11.12.1 Company Overview 94
11.12.2 Product Portfolio 94
11.12.3 Recent Developments 94
12 Related Reports 95
?